Khala Mercy Mpho, van der Spoel van Dijk Anneke, Hildah Mfengwana Polo-Ma-Abiele
Department of Health Science, Central University of Technology, Free State, Private Bag X20539, Bloemfontein, 9300 South Africa.
Department of Medical Microbiology, University of the Free State, Free State, PO Box 339, Bloemfontein, 9300 South Africa.
Iran Biomed J. 2024 Sep 1;28(5 & 6):265-72. doi: 10.61186/ibj.4356.
Tuberculosis (TB) is among the top ten causes of death in South Africa and worldwide and remains a high priority of the World Health Organization. South Africa has a rich tradition for using medicinal plants to treat various diseases, including TB; however, the safety and efficacy of these plants require thorough investigation and confirmation. This study examined the anti-inflammatory and anti-TB activities of three indigenous medicinal plants against two strains of TB.
Water and methanol root extracts of E. elephantina (Burch.), L. lanceolata, and T. burchellianum were tested in vitro for their activity against Latin American Mediterranean (LAM) and East African Indian (EAI) lineages. Additionally, the phytochemical screening, anti-inflammatory properties, and cytotoxicity activities of these extracts were evaluated.
Aqueous extracts of E. elephantina and T. burchellianum exhibited anti-inflammatory activity at a concentration of 200 μg/ml, while L. lanceolata demonstrated no activity on macrophage cells. The E. elephantina extracts showed no cytotoxicity against the Vero cells at high concentration (200 μg/ml); however, both L. lanceolata and T. burchellianum aqueous extracts were found to be cytotoxic at 200 μg/ml. Unfortunately, none of the three plant extracts showed anti-TB activity against LAM and EAI stains.
While the tested extracts lacked direct anti-TB effects, their anti-inflammatory properties and safety profile highlight their potential for adjunctive therapy in TB management or other inflammatory conditions. Further studies are needed to explore the mechanisms and potential clinical applications of these findings.
结核病是南非和全球十大死因之一,仍然是世界卫生组织的高度优先事项。南非有着使用药用植物治疗包括结核病在内的各种疾病的丰富传统;然而,这些植物的安全性和有效性需要进行彻底调查和确认。本研究考察了三种本土药用植物对两株结核杆菌的抗炎和抗结核活性。
对象牙叶天料木(Burch.)、披针叶李和布尔切尔山龙眼的水提物和甲醇根提取物进行体外测试,考察其对拉丁美洲地中海(LAM)和东非印度(EAI)分支的活性。此外,还对这些提取物进行了植物化学筛选、抗炎特性和细胞毒性活性评估。
象牙叶天料木和布尔切尔山龙眼的水提物在浓度为200μg/ml时表现出抗炎活性,而披针叶李对巨噬细胞无活性。象牙叶天料木提取物在高浓度(200μg/ml)下对非洲绿猴肾细胞无细胞毒性;然而,披针叶李和布尔切尔山龙眼的水提物在200μg/ml时均具有细胞毒性。遗憾的是,三种植物提取物均未对LAM和EAI菌株表现出抗结核活性。
虽然测试的提取物缺乏直接的抗结核作用,但其抗炎特性和安全性表明它们在结核病管理或其他炎症性疾病辅助治疗方面具有潜力。需要进一步研究来探索这些发现的机制和潜在临床应用。